The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 4:03 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #45. StoneCalibre Anatrace, a part of Affymetrix, Inc.

Acquirer: StoneCalibre
Acquiree: Anatrace, a part of Affymetrix, Inc. (AFFX)
Details: StoneCalibre today announced the completion of the acquisition of Anatrace, a part of Affymetrix, Inc. (NASDAQ: AFFX). Headquartered in Maumee, Ohio, Anatrace is a highly specialized developer, manufacturer and global distributor of unique, high purity detergents and synthetic lipids for use in membrane protein studies.



Open the AFFX Page at The Online Investor »

Company Name: 
Affymetrix Inc
Website: 
www.affymetrix.com
Sector: 
Biotechnology
 

Open the AFFX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (1.83 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 45 of 83 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.